Osteogenic differentiation is inhibited and angiogenic expression is enhanced in MC3T3-E1 cells cultured on three-dimensional scaffolds

American Journal of Physiology - Cell Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Jarrahy, Reza ^a,b   Huang, Weibiao ^a,b   Rudkin, George H ^a,b   Lee, Jane M ^a   Ishida, Kenji ^a   Berry, Micah D ^a   Sukkarieh, Modar ^a   Wu, Benjamin M ^c   Yamaguchi, Dean T ^a   Miller, Timothy A ^a,b,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d Plastic Surgery Laboratory   (United States)

Author keywords

Angiogenesis; Gene expression; Osteogenesis

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; POLYGLACTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; LACTIC ACID; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCALCIN; OSTEOCYTES; POLYGLYCOLIC ACID; POLYMERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 22444435376     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00196.2004     Document Type: Article

References (59)

1. Auerbach R, Lewis R, Shinners B, Kubai L, and Akhtar N. Angiogenesis assays: a critical overview. Clin Chem 49: 32-40, 2003.
2. Blum JS, Barry MA, and Mikos AG. Bone regeneration through transplantation of genetically modified cells. Clin Plast Surg 30: 611-620, 2003.
3. Blum JS, Barry MA, Mikos AG, and Jansen JA. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum Gene Ther 14: 1689-1701, 2003.
4. Chang SC, Chuang HL, Chen YR, Chen JK, Chung HY, Lu YL, Lin HY, Tai CL, and Lou J. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 10: 2013-2019, 2003.
5. Chang SC, Wei FC, Chuang H, Chen YR, Chen JK, Lee KC, Chen PK, Tai CL, and Lou J. Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast Reconstr Surg 112: 1841-1850, 2003.
6. Chen G, Ushida T, and Tateishi T. A biodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res 51: 273-279, 2000.
7. Chen Y, Cheung KM, Kung HF, Leong JC, Lu WW, and Luk KD. In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene. Biochem Biophys Res Commun 298: 121-127, 2002.
8. Chen Y, Luk KD, Cheung KM, Xu R, Lin MC, Lu WW, Leong JC, and Kung HF. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther 10: 1345-1353, 2003.
9. Cukierman E, Pankov R, Stevens DR, and Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 294: 1708-1712, 2001.
10. Damasio EE, Cerri R, Masoudi B, and Risso M. Bone marrow aspiration from the posterior iliac crest and spine using a sterile and pyrogen free disposable spinal needle (Yale spinal 18 Gx31/2″) without local anesthetic. Haematologica 85: 871, 2000.
11. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, and Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
12. Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, and Wang D. Gene therapy approaches for bone regeneration. Cells Tissues Organs 176: 95-108, 2004.
13. Gerber HP and Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 10: 223-228, 2000.
14. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628, 1999.
15. Goidin D, Mamessier A, Staquet MJ, Schmitt D, and Berthier-Vergnes O. Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem 295: 17-21, 2001.
16. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, and Rosier RN. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am 83: 98-103, 2001.
17. Harper J and Kalgsbrun M. Cartilage to bone-angiogenesis leads the way. Nat Med 5: 617-618, 1999.
18. Huang W, Carlsen B, Wulur I, Rudkin G, Ishida K, Wu B, Yamaguchi DT, and Miller TA. BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 299: 325-334, 2004.
19. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, and Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36: 17-28, 1997.
20. Ishaug SL, Yaszemski MJ, Bizios R, and Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 28: 1445-1453, 1994.
21. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, and Mikos AG. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 19: 1405-1412, 1998.
22. Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, Long MW. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 18: 954-958, 2000.
23. Kim BS, Nikolovski J, Bonadio J, Smiley E, and Mooney DJ. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res 251: 318-328, 1999.
24. Kim HD and Valentini RF. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59: 573-584, 2002.
25. Kim HH, Lee SE, Chung WJ, Choi Y, Kwack K, Kim SW, Kim MS, Park H, and Lee ZH. Stabilization of hypoxia-inducible factor-1α is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine 17: 14-27, 2002.
26. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, and Martin GR. Basement membrane complexes with biological activity. Biochemistry 25: 312-318, 1986.
27. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, and Martin GR. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21: 6188-6193, 1982.
28. Laurencin CT, Attawia MA, Lu LQ, Borden MD, Lu HH, Gorum WJ, and Lieberman JR. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials 22: 1271-1277, 2001.
29. Lewinson D, Maor G, Rozen N, Rabinovich I, Stahl S, and Rachmiel A. Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 116: 381-388, 2001.
30. Lu HH, El-Amin SF, Scott KD, and Laurencin CT. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res 64: 465-474, 2003.
31. Mauney JR, Blumberg J, Pirun M, Volloch V, Vunjak-Novakovic G, and Kaplan DL. Osteogenic differentiation of human bone marrow stromal cells on partially demineralized bone scaffolds in vitro. Tissue Eng 10: 81-92, 2004.
32. Mikos AG, Lyman MD, Freed LE, and Langer R. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 15: 55-58, 1994.
33. Murphy WL, Kohn DH, and Mooney DJ. Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res 50: 50-58, 2000.
34. Murphy WL, Peters MC, Kohn DH, and Mooney DJ. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-coglycolide) scaffolds for tissue engineering. Biomaterials 21: 2521-2527, 2000.
35. Murphy WL, Simmons CA, Kaigler D, and Mooney DJ. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83: 204-210, 2004.
36. Nussenbaum B, Rutherford RB, Teknos TN, Dornfeld KJ, and Krebsbach PH. Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy. Hum Gene Ther 14: 1107-1115, 2003.
37. Nuttelman CR, Tripodi MC, and Anseth KS. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res 68: 773-782, 2004.
38. Ochi K, Chen G, Ushida T, Gojo S, Segawa K, Tai H, Ueno K, Ohkawa H, Mori T, Yamaguchi A, Toyama Y, Hata J, and Umezawa A. Use of isolated mature osteoblasts in abundance acts as desired-shaped bone regeneration in combination with a modified poly-DL-lactic-coglycolic acid (PLGA)-collagen sponge. J Cell Physiol 194: 45-53, 2003.
39. Park J, Ries J, Gelse K, Kloss F, von der Mark K., Wiltfang J., Neukam FW, and Schneider H. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 10: 1089-1098, 2003.
40. Paulman PM. Bone marrow sampling. Am Fam Physician 40: 85-89, 1989.
41. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, and Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 65: 489-497, 2003.
42. Peter SJ, Lu L, Kim DJ, and Mikos AG. Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials 21: 1207-1213, 2000.
43. Porter BD, Oldham JB, He SL, Zobitz ME, Payne RG, An KN, Currier BL, Mikos AG, and Yaszemski MJ. Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng 122: 286-288, 2000.
44. Rago R, Mitchen J, and Wilding G. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191: 31-34, 1990.
45. Ribatti D, Conconi MT, Nico B, Baiguera S, Corsi P, Parnigotto PP, and Nussdorfer GG. Angiogenic response induced by acellular brain scaffolds grafted onto the chick embryo chorioallantoic membrane. Brain Res 989: 9-15, 2003.
46. Rowe NM, Mehrara BJ, Luchs JS, Dudziak ME, Steinbrech DS, Illei PB, Fernandez GJ, Gittes GK, and Longaker MT. Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 42: 470-475, 1999.
47. Rutherford RB, Nussenbaum B, and Krebsbach PH. Bone morphogenetic protein 7 ex vivo gene therapy. Drug News Perspect 16: 5-10, 2003.
48. Saito N, Okada T, Horiuchi H, Ota H, Takahashi J, Murakami N, Nawata M, Kojima S, Nozaki K, and Takaoka K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 32: 381-386, 2003.
49. Sato M, Ishikawa O, and Miyachi Y. Distinct patterns of collagen gene expression are seen in normal and keloid fibroblasts grown in three-dimensional culture. Br J Dermatol 138: 938-943, 1998.
50. Shea LD, Wang D, Franceschi RT, and Mooney DJ. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 6: 605-617, 2000.
51. Steinbrech DS, Mehrara BJ, Saadeh PB, Greenwald JA, Spector JA, Gittes GK, and Longaker MT. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol 278: C853-C860, 2000.
52. Steinbrech DS, Mehrara BJ, Saadeh PB, Chin G, Dudziak ME, Gerrets RP, Gittes GK, and Longaker MT. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 104: 738-747, 1999.
53. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, and Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661, 2002.
54. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K, Sasaki K, Kobune M, Yamashita T, and Hamada H. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7: 354-365, 2003.
55. Turgeman G, Aslan H, Gazit Z, and Gazit D. Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 4: 390-394, 2002.
56. 1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95: 14821-14826, 1998.
57. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, and Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245, 1997.
58. Webb K, Li W, Hitchcock RW, Smeal RM, Gray SD, and Tresco PA. Comparison of human fibroblast ECM-related gene expression on elastic three-dimensional substrates relative to two-dimensional films of the same material. Biomaterials 24: 4681-4690, 2003.
59. Yaszemski MJ, Payne RG, Hayes WC, Langer R, and Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17: 175-185, 1996.